Trial Profile
Effect of a Combination of Daclatasvir, Asunaprevir, and BMS-791325 on the Pharmacokinetics of Selective Serotonin Reuptake Inhibitors in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Asunaprevir/becabluvir/daclatasvir (Primary) ; Beclabuvir (Primary) ; Escitalopram; Sertraline
- Indications Anxiety disorders; Hepatitis C; Major depressive disorder; Premenstrual dysphoric disorder
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 09 Feb 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 30 Jun 2014 New trial record